Bispecific antibody targets VEGF-A, angiopoietin-2 in DME
6 monthes ago - By Healio
The bispecific monoclonal antibody RG7716, which binds to and inactivates both VEGF-A and angiopoietin-2, met its primary endpoint of significant improvement in best corrected visual acuity compared with ranibizumab treatment in a phase 2 study of patients with diabetic macular edema, according to a news release from Genentech, a member of the Roche group.
Results from the BOULEVARD study were delivered at Angiogenesis, Exudation, and Degeneration 2018 hosted by Bascom Palmer Eye Institute in Miami.
Monthly intravitreal injections of either 1.5 mg or 6 mg of RG7716 or of 0.3 mg
Read more ...
The headlines of Master Doctor
Coal Miners at High Risk of Developing Deadly Lung Fibrosis
Coal miners are at an increased risk of developing progressive massive fibrosis. Coal mine operators and coal miners need to be educated about the harmful effects of coal mine...
How to Identify Risk of Gestational Diabetes During Pregnancy?
A blood test done early in the first trimester of pregnancy can help women make lifestyle changes even before gestational diabetes can develop.
Man told he'd never walk or talk because of rare disease stuns doctors with...
Macauley Collinson, from Lancaster, suffers with the rare Moebius Syndrome - a rare neurological condition which affects the nerves controlling facial expression and eye movement.
Gene-to-gene Interaction can be Understood Better With the New Statistical...
Gene-to-gene Interaction can be understood better with the New Statistical Method- AA9int. This method can be used to evaluate gene-to-gene interactions associated with cancer...
Patients are discussing their conditions online instead of seeking...
Experts say web giants such as Facebook and Instagram had a 'moral duty' to help the 'cash strapped' NHS reach troubled young people in the UK.
New cancer pill stops tumor cells repairing - making them weaker
Researchers based at the Francis Crick Institute in London and Oxford University are developing a drug that blocks the ability of tumour cells to repair themselves.
Organ Donation Following Neurologic and Circulatory Determination of Death
Objectives: To describe important considerations during the process of caring for critically ill children who may be potential organ donors and supporting the family during the...
Lead levels in baby food ‘worrisome' but industry can fix the problem
Laboratory analysis of 50 big-name baby foods all showed the presence of at least one heavy metal, with two-thirds having “worrisome” levels, according to information from...
Weight Loss: More Protein can Reduce Fatty Liver
Increase in dietary protein is linked to reduce the liver's fat content in people with nonalcoholic fatty liver disease .
FDA Approves First Generic EpiPen
Teva's new allergy medicine is a welcome alternative to the high-cost brand name.